Stocks and Investing Stocks and Investing
Thu, March 31, 2022
Wed, March 30, 2022
Tue, March 29, 2022
Mon, March 28, 2022
Sun, March 27, 2022
Fri, March 25, 2022

John Abbott Maintained (ARCT) at Buy with Decreased Target to $105 on, Mar 25th, 2022


Published on 2024-10-27 20:11:57 - WOPRAI, John Abbott
  Print publication without navigation


John Abbott of Wells Fargo, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy with Decreased Target from $107 to $105 on, Mar 25th, 2022.

John has made no other calls on ARCT in the last 4 months.



There are 2 other peers that have a rating on ARCT. Out of the 2 peers that are also analyzing ARCT, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steven Seedhouse of "Raymond James" Upgraded from Sell to Hold on, Monday, January 31st, 2022


This is the rating of the analyst that currently disagrees with John


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $86 on, Tuesday, March 15th, 2022